APA 2016:暴饮暴食症筛查的临床应用研究

2016-06-03 Seven L 译 MedSci原创

美国精神病学协会年会上提出了,精神科医生和初级保健提供者使用暴饮暴食症筛查工具具有临床可用性。“我们想评估初级保健医生和精神科医生对暴食症的知识和态度,以及治疗,”来自全球医疗团队的高级主任Barry K. Herman博士说,“我们还想调查7项暴饮暴食症筛(BEDS-7)查的感知价值和易用性。”该研究纳入了122名初级保健医生(PCPs)和123名精神科医生。调查评估了他们对暴饮暴食症的知识、信

美国精神病学协会年会上提出了,精神科医生和初级保健提供者使用暴饮暴食症筛查工具具有临床可用性。

“我们想评估初级保健医生和精神科医生对暴食症的知识和态度,以及治疗,”来自全球医疗团队的高级主任Barry K. Herman博士说,“我们还想调查7项暴饮暴食症筛(BEDS-7)查的感知价值和易用性。”

该研究纳入了122名初级保健医生(PCPs)和123名精神科医生。调查评估了他们对暴饮暴食症的知识、信念和态度,以及BEDS-7的价值和易用性。

总的来说, PCPs(P <0.001)和精神科医生(P < 0.05)对暴饮暴食症的知识在显著增加。与精神科医生相比,PCPs对暴饮暴食症的认识要差一些 (P < 0.001)。

PCPs和精神科医生报道了相似的关于暴食症的重要性,不过PCPs报道的暴食症的舒适程度显著低于精神科医生。

BEDS-7在PCPs和精神科医生的使用率分别为32%和26.8%。所有BEDS-7使用者易用性评价是“非常有价值”或“有价值的”和“很容易”或“比较容易”。

“我们发现精神科医生对暴食症的认识和治疗的自信更高,但是重要性的认识在两组相似。我们还发现PCPs更有可能使用BEDS-7进行筛查,”Herman说,“使用BEDS-7的人群表示是有价值的和易于使用的。”

原始出处:


Herman BK, et al. The use and value of the seven-item binge-eating disorder screener in clinical practice. Presented at: American Psychiatric Association Annual Meeting; May 14-18, 2016; Atlanta.

Binge-eating disorder screener may be clinically useful for psychiatrists, PCPs.Healio.June 2, 2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2054008, encodeId=b7602054008b2, content=<a href='/topic/show?id=3ca560208cc' target=_blank style='color:#2F92EE;'>#暴食症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60208, encryptionId=3ca560208cc, topicName=暴食症)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Jan 19 17:00:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797375, encodeId=3dcb1e9737561, content=<a href='/topic/show?id=99e022e94a0' target=_blank style='color:#2F92EE;'>#临床应用研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22794, encryptionId=99e022e94a0, topicName=临床应用研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Fri Dec 23 02:00:00 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1835623, encodeId=db73183562384, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Mon Nov 28 23:00:00 CST 2016, time=2016-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338149, encodeId=c28213381493c, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2620, encryptionId=cd2a262068, topicName=APA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sun Jun 05 10:00:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417417, encodeId=da6b141e4171d, content=<a href='/topic/show?id=29ad60210f3' target=_blank style='color:#2F92EE;'>#暴饮暴食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60210, encryptionId=29ad60210f3, topicName=暴饮暴食)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09a33274256, createdName=redcrab, createdTime=Sun Jun 05 10:00:00 CST 2016, time=2016-06-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2054008, encodeId=b7602054008b2, content=<a href='/topic/show?id=3ca560208cc' target=_blank style='color:#2F92EE;'>#暴食症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60208, encryptionId=3ca560208cc, topicName=暴食症)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Jan 19 17:00:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797375, encodeId=3dcb1e9737561, content=<a href='/topic/show?id=99e022e94a0' target=_blank style='color:#2F92EE;'>#临床应用研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22794, encryptionId=99e022e94a0, topicName=临床应用研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Fri Dec 23 02:00:00 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1835623, encodeId=db73183562384, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Mon Nov 28 23:00:00 CST 2016, time=2016-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338149, encodeId=c28213381493c, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2620, encryptionId=cd2a262068, topicName=APA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sun Jun 05 10:00:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417417, encodeId=da6b141e4171d, content=<a href='/topic/show?id=29ad60210f3' target=_blank style='color:#2F92EE;'>#暴饮暴食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60210, encryptionId=29ad60210f3, topicName=暴饮暴食)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09a33274256, createdName=redcrab, createdTime=Sun Jun 05 10:00:00 CST 2016, time=2016-06-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2054008, encodeId=b7602054008b2, content=<a href='/topic/show?id=3ca560208cc' target=_blank style='color:#2F92EE;'>#暴食症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60208, encryptionId=3ca560208cc, topicName=暴食症)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Jan 19 17:00:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797375, encodeId=3dcb1e9737561, content=<a href='/topic/show?id=99e022e94a0' target=_blank style='color:#2F92EE;'>#临床应用研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22794, encryptionId=99e022e94a0, topicName=临床应用研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Fri Dec 23 02:00:00 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1835623, encodeId=db73183562384, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Mon Nov 28 23:00:00 CST 2016, time=2016-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338149, encodeId=c28213381493c, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2620, encryptionId=cd2a262068, topicName=APA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sun Jun 05 10:00:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417417, encodeId=da6b141e4171d, content=<a href='/topic/show?id=29ad60210f3' target=_blank style='color:#2F92EE;'>#暴饮暴食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60210, encryptionId=29ad60210f3, topicName=暴饮暴食)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09a33274256, createdName=redcrab, createdTime=Sun Jun 05 10:00:00 CST 2016, time=2016-06-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2054008, encodeId=b7602054008b2, content=<a href='/topic/show?id=3ca560208cc' target=_blank style='color:#2F92EE;'>#暴食症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60208, encryptionId=3ca560208cc, topicName=暴食症)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Jan 19 17:00:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797375, encodeId=3dcb1e9737561, content=<a href='/topic/show?id=99e022e94a0' target=_blank style='color:#2F92EE;'>#临床应用研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22794, encryptionId=99e022e94a0, topicName=临床应用研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Fri Dec 23 02:00:00 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1835623, encodeId=db73183562384, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Mon Nov 28 23:00:00 CST 2016, time=2016-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338149, encodeId=c28213381493c, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2620, encryptionId=cd2a262068, topicName=APA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sun Jun 05 10:00:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417417, encodeId=da6b141e4171d, content=<a href='/topic/show?id=29ad60210f3' target=_blank style='color:#2F92EE;'>#暴饮暴食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60210, encryptionId=29ad60210f3, topicName=暴饮暴食)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09a33274256, createdName=redcrab, createdTime=Sun Jun 05 10:00:00 CST 2016, time=2016-06-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2054008, encodeId=b7602054008b2, content=<a href='/topic/show?id=3ca560208cc' target=_blank style='color:#2F92EE;'>#暴食症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60208, encryptionId=3ca560208cc, topicName=暴食症)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Jan 19 17:00:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797375, encodeId=3dcb1e9737561, content=<a href='/topic/show?id=99e022e94a0' target=_blank style='color:#2F92EE;'>#临床应用研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22794, encryptionId=99e022e94a0, topicName=临床应用研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Fri Dec 23 02:00:00 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1835623, encodeId=db73183562384, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Mon Nov 28 23:00:00 CST 2016, time=2016-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338149, encodeId=c28213381493c, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2620, encryptionId=cd2a262068, topicName=APA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sun Jun 05 10:00:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417417, encodeId=da6b141e4171d, content=<a href='/topic/show?id=29ad60210f3' target=_blank style='color:#2F92EE;'>#暴饮暴食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60210, encryptionId=29ad60210f3, topicName=暴饮暴食)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09a33274256, createdName=redcrab, createdTime=Sun Jun 05 10:00:00 CST 2016, time=2016-06-05, status=1, ipAttribution=)]